Non-genomic inhibition of human P2X7 purinoceptor by 17β-oestradiol

Journal of Physiology

Volumn 508, Issue 3, 1998, Pages 659-666

  Carlo Toumaniantz, Chrystelle ^a   Loirand, Gervaise ^a   Ferrier, Laurent ^a   Pacaud, Pierre ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CATION CHANNEL; ESTRADIOL; ESTROGEN; PROGESTERONE; PURINE P2X RECEPTOR; ETHIDIUM BROMIDE; PURINERGIC P2X7 RECEPTOR;

ANIMAL CELL; ARTICLE; HUMAN; HUMAN CELL; ION CURRENT; KIDNEY CELL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; SIMIAN VIRUS 40; ACTION POTENTIAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; EXPRESSION VECTOR; MACROPHAGE; MEMBRANE CURRENT; MEMBRANE POTENTIAL; MODULATION; OSTEOLYSIS; PATCH CLAMP TECHNIQUE; PROTEIN EXPRESSION; WHOLE CELL PATCH CLAMP;

ADENOSINE TRIPHOSPHATE; AFFINITY LABELS; ANIMALS; CALCIUM; CATIONS; COS CELLS; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ETHIDIUM; HUMANS; MAGNESIUM; MEMBRANE POTENTIALS; MENOPAUSE; PATCH-CLAMP TECHNIQUES; RECEPTORS, PURINERGIC P2;

EID: 0031921573     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-7793.1998.659bp.x     Document Type: Article

References (21)

1. DUBYAK, G. R. & EL-MOATASSIM, C. (1993). Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. American Journal of Physiology 265, C577-606.
2. FERRARI, D., CHIOZZI, P., FALZONI, S., HANAU, S. & DI VIRGILIO, F. (1997). Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin. Journal of Experimental Medicine 185, 579-582.
3. FREAY, A. D., CURTIS, S. W., KORACH, S. K. & RUBANYI, G. M. (1997). Mechanism of vascular smooth muscle relaxation by estrogen in depolarized rat and mouse aorta. Circulation Research 81, 242-248.
4. GISCLARD, V., MILLER, V. M. & VANHOUTTE, P. M. (1988). Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. Journal of Pharmacology and Experimental Therapeutics 244, 19-22.
5. JIANG, C., SARREL, P. M., LINDSAY, D. C., POOLE-WILSON, P A. & COLLINS, P. (1991). Endothelium-independent relaxation of rabbit coronary artery by 17β-estradiol in vitro. British Journal of Pharmacology 104, 1033-1037.
6. JILKA, R. L., HANGOC, G., GIRASOLE, G., PASSERI, G., WILLIAMS, D. C., ABRAMS, J. S., BOYCE, B., BROXMEYER, H. & MANOLAGAS, S. C. (1992). Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257, 88-91.
7. JURMAN, M. E., BOLAND, L. M. & YELLEN, G. (1994). Visual identification of individual transfected cells for electrophysiology using antibody-coated beads. BioTechniques 17, 876-881.
8. KITAZAWA, T., HAMADA, E., KITAZAWA, K. & GAZNABI, A. K. M. (1997). Non-genomic mechanism of 17β-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle. Journal of Physiology 499, 497-511.
9. MCCUTCHAN, J. H. & PAGANO, J. S. (1968). Enhancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethyl-aminoethyl-dextran. Journal of National Cancer Institute 41, 351-357.
10. MCEWEN, B. S. (1991). Non-genomic and genomic effects of steroids on neural activity. Trends in Pharmacological Sciences 12, 141-147.
11. NATHAN, L. & CHAUDHURI, G. (1997). Estrogens and atherosclerosis. Annual Review of Pharmacology and Toxicology 37, 477-515.
12. PACIFICI, R. (1996). Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. Journal of Bone and Mineral Research 11, 1043-1051.
13. PIETRAS, R. J. & SZEGO, C. M. (1977). Specific binding sites for estrogen receptors at the outer surfaces of isolated endometrial cells. Nature 265, 69-72.
14. POLI, V., BALENA, R., FATTORI, E., MARKATOS, A., YAMAMOTO, M., TANAKA, H., CILIBERTO, G., RODAN, G. A. & COSTANTINI, F. (1994). Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO Journal 13, 1189-1196.
15. 7. Journal of Biological Chemistry 272, 5482-5486.
16. SELYE, H. (1941). Anesthetic effects of steroid hormones. Proceedings of the Society for Experimental Biology and Medicine 46, 116-121.
17. SQUADRITO, F., ALTAVILLA, D., SQUADRITO, G., CAMPO, G. M., ARLOTTA, M., ARCORACI, V., MINUTOLI, L., SERRANO, M., SAITTA, A. & CAPUTI, A. P. (1997). 17β-Oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat. European Journal of Pharmacology 335, 185-192.
18. SUDHIR, K., CHOU, T. M., MULLEN, W. L., HAUSMANN, D., COLLINS, P., YOCK, P. G. & CHATTERJEE, K. (1995). Mechanism of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. Journal of the American College of Cardiology 26, 807-814.
19. UGUR, M., DRUMMOND, R. M., ZOU, H., SHENG, P., SINGER, J. J. & WALSH, J. V. JR (1997). An ATP-gated cation channel with some P2Z-like characteristics in gastric smooth muscle cells of toad. Journal of Physiology 498, 427-442.
20. WEHLING, M. (1997). Specific, nongenomic actions of steroid hormones. Annual Review of Physiology 59, 365-393.
21. WHITE, R., LEES, J. A., NEEDHAM, M., HAM, J. & PARKER, M. (1987). Structural organization and expression of the mouse estrogen receptor. Molecular Endocrinology 1, 735-744.